PFM Health Sciences’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $37.5M | Buy |
+94,375
| New | +$26.9M | 3.22% | 5 |
|
|
2025
Q4 | – | Sell |
-3,648
| Closed | -$949K | – | 90 |
|
|
2025
Q3 | $949K | Sell |
3,648
-105,863
| -97% | -$27.8M | 0.07% | 70 |
|
|
2025
Q2 | $26.8M | Buy |
109,511
+46,273
| +73% | +$11.5M | 2.28% | 15 |
|
|
2025
Q1 | $16.7M | Sell |
63,238
-19,799
| -24% | -$5.35M | 1.21% | 28 |
|
|
2024
Q4 | $21.1M | Sell |
83,037
-18,917
| -19% | -$5.07M | 1.31% | 26 |
|
|
2024
Q3 | $32.3M | Sell |
101,954
-23,386
| -19% | -$8.32M | 1.83% | 19 |
|
|
2024
Q2 | $46.8M | Hold |
125,340
| – | – | 2.32% | 12 |
|
|
2024
Q1 | $43.5M | Hold |
125,340
| – | – | 2.04% | 12 |
|
|
2023
Q4 | $57.4M | Sell |
125,340
-40,726
| -25% | -$20.1M | 3.44% | 6 |
|
|
2023
Q3 | $80.8M | Hold |
166,066
| – | – | 3.81% | 2 |
|
|
2023
Q2 | $74.3M | Hold |
166,066
| – | – | 2.88% | 6 |
|
|
2023
Q1 | $80.6M | Hold |
166,066
| – | – | 3.56% | 5 |
|
|
2022
Q4 | $85.1M | Hold |
166,066
| – | – | 3.05% | 6 |
|
|
2022
Q3 | $80.6M | Hold |
166,066
| – | – | 2.92% | 6 |
|
|
2022
Q2 | $77.7M | Hold |
166,066
| – | – | 2.97% | 9 |
|
|
2022
Q1 | $72.3M | Buy |
166,066
+26,646
| +19% | +$11.1M | 2.7% | 11 |
|
|
2021
Q4 | $64.7M | Hold |
139,420
| – | – | 2.2% | 12 |
|
|
2021
Q3 | $54.3M | Sell |
139,420
-2,986
| -2% | -$1.27M | 1.6% | 24 |
|
|
2021
Q2 | $63M | Hold |
142,406
| – | – | 1.98% | 18 |
|
|
2021
Q1 | $59.7M | Buy |
142,406
+64,666
| +83% | +$25.8M | 1.82% | 19 |
|
|
2020
Q4 | $31.9M | Hold |
77,740
| – | – | 1.12% | 35 |
|
|
2020
Q3 | $32.2M | Sell |
77,740
-8,280
| -10% | -$3.33M | 1.49% | 22 |
|
|
2020
Q2 | $33.4M | Sell |
86,020
-17,010
| -17% | -$6.36M | 1.73% | 21 |
|
|
2020
Q1 | $32.4M | Buy |
103,030
+23,484
| +30% | +$7.92M | 2.66% | 15 |
|
|
2019
Q4 | $29.2M | Buy |
+79,546
| New | +$25.2M | 1.39% | 27 |
|
|
2019
Q3 | – | Sell |
-562,177
| Closed | -$149M | – | 84 |
|
|
2019
Q2 | $149M | Buy |
562,177
+197,704
| +54% | +$50.1M | 2.83% | 5 |
|
|
2019
Q1 | $97M | Sell |
364,473
-43,620
| -11% | -$12.6M | 2.14% | 12 |
|
|
2018
Q4 | $117M | Buy |
408,093
+67,083
| +20% | +$21.3M | 3.11% | 5 |
|
|
2018
Q3 | $115M | Buy |
341,010
+31,909
| +10% | +$10.4M | 1.69% | 13 |
|
|
2018
Q2 | $92M | Sell |
309,101
-11,349
| -4% | -$3.32M | 1.44% | 17 |
|
|
2018
Q1 | $86.1M | Buy |
320,450
+25,970
| +9% | +$7.03M | 1.75% | 16 |
|
|
2017
Q4 | $73.1M | Buy |
294,480
+93,290
| +46% | +$23M | 1.73% | 22 |
|
|
2017
Q3 | $49M | Sell |
201,190
-135,117
| -40% | -$33.1M | 0.96% | 40 |
|
|
2017
Q2 | $80.9M | Sell |
336,307
-58,535
| -15% | -$13.3M | 2.18% | 14 |
|
|
2017
Q1 | $81.4M | Buy |
394,842
+43,051
| +12% | +$8.9M | 2.04% | 14 |
|
|
2016
Q4 | $71.8M | Buy |
351,791
+94,479
| +37% | +$18M | 2.02% | 18 |
|
|
2016
Q3 | $45.5M | Buy |
+257,312
| New | +$44.7M | 1.33% | 29 |
|
|
2015
Q4 | – | Sell |
-186,935
| Closed | -$33.5M | – | 74 |
|
|
2015
Q3 | $33.5M | Sell |
186,935
-256,128
| -58% | -$47.3M | 0.94% | 38 |
|
|
2015
Q2 | $84.7M | Buy |
443,063
+44,371
| +11% | +$8.24M | 2.15% | 13 |
|
|
2015
Q1 | $71M | Sell |
398,692
-146,973
| -27% | -$23.3M | 1.96% | 18 |
|
|
2014
Q4 | $78.4M | Buy |
545,665
+327,096
| +150% | +$44.7M | 1.83% | 20 |
|
|
2014
Q3 | $28.5M | Buy |
218,569
+46,955
| +27% | +$5.97M | 0.66% | 40 |
|
|
2014
Q2 | $21.9M | Sell |
171,614
-160,769
| -48% | -$19M | 0.44% | 47 |
|
|
2014
Q1 | $37.5M | Buy |
332,383
+199,953
| +151% | +$20.8M | 0.68% | 42 |
|
|
2013
Q4 | $13.7M | Buy |
132,430
+7,609
| +6% | +$745K | 0.27% | 49 |
|
|
2013
Q3 | $11.7M | Buy |
+124,821
| New | +$11.5M | 0.28% | 54 |
|
Other funds holding HUM
SC
PFM Health Sciences's HUM Position: Q2 2026 in Review
PFM Health Sciences opened a new position in Humana (HUM) in Q2 2026: 94,375 shares worth $37.5M. The stake represents 3.22% of the portfolio and ranks #5 among its holdings. This is a return to the name: PFM Health Sciences previously reported a position in HUM as recently as Q3 2025.
PFM Health Sciences first reported a position in HUM in Q3 2013 and has held it in 46 quarters since. The position peaked at $149M in Q2 2019. 924 funds tracked by Wall St. Rank hold HUM as of Q2 2026.
- PFM Health Sciences held 94,375 shares of Humana worth $37.5M as of Q2 2026.
- Humana was a new PFM Health Sciences position in Q2 2026.
- Humana made up 3.22% of PFM Health Sciences's portfolio in Q2 2026, its #5 holding.
- PFM Health Sciences first reported a position in Humana in Q3 2013 and has held it in 46 quarters since.
- PFM Health Sciences's Humana position peaked at $149M in Q2 2019.
- 924 funds tracked by Wall St. Rank held Humana as of Q2 2026.
Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.